Study on Placebo Pills in Chronic Pain Treatment

Understanding Placebo Effects

A recent study explored how various factors might predict which patients could experience a beneficial “placebo effect” in chronic pain treatment. A placebo, defined as an inactive substance, is administered to patients with no intent to affect their medical condition. Placebos are often utilized in clinical trials to compare the effects of new treatments against inactive substances. Some individuals report positive physical outcomes after taking a placebo, referred to as the “placebo effect.” The mechanisms behind this phenomenon remain unclear, though research indicates it may involve psychological and neurobiological interactions. Gaining a deeper understanding of placebo effects could enhance the design and interpretation of drug trials and potentially offer alternative treatment avenues for certain patients.

Research Overview

Researchers at Northwestern University in Chicago conducted a study to examine the impact of placebo pills on chronic pain and to identify predictive factors for experiencing a beneficial placebo effect. Their findings were published in Nature Communications. The study involved 63 patients suffering from chronic back pain over an eight-week period. Initially, participants underwent an assessment before being randomly assigned to one of two groups: 43 patients received placebo pills, while 20 patients were placed in a “no treatment” or control group. Participants documented their daily pain levels using a smartphone app and attended four study visits, during which they underwent brain scans and completed detailed psychological questionnaires.

Findings on Pain Reduction

Results indicated that patients receiving placebo pills experienced a greater reduction in pain compared to those in the control group, suggesting that the placebo pills effectively induced pain relief. Within the placebo group, researchers identified two subsets: “responders” (24 patients) who exhibited a significant placebo effect and “non-responders” (19 patients). Further analysis of brain scans and psychological assessments revealed distinct differences between the two groups. Responders demonstrated a thicker cortical sensory area and enhanced prefrontal functional pathways. Psychologically, responders were characterized by openness to new experiences, emotional self-awareness, sensitivity to pain, and mindfulness of their surroundings. These traits may serve as indicators for predicting which patients are likely to benefit from placebo effects.

Implications for Chronic Pain Treatment

This study sheds light on the intricate mechanisms behind placebo effects. Although the findings are preliminary, the researchers propose that healthcare professionals should evaluate whether certain chronic pain patients could benefit from placebo therapy. Utilizing personality and psychological questionnaires may provide a straightforward method for predicting placebo responders. Such therapies could offer a cost-effective alternative without the side effects associated with active medications.

References

Vachon-Presseau E, Berger SE, Abdullah TB, et al. Brain and psychological determinants of placebo pill response in chronic pain patients. Nature Communications DOI:10.1038/s41467-018-5859-1.
EurekAlert. Sugar pills relieve pain for chronic pain patients. 12 Sept 2018. https://www.eurekalert.org/pub_releases/2018-09/nu-spr091218.php